A detailed history of American Century Companies Inc transactions in Organon & Co. stock. As of the latest transaction made, American Century Companies Inc holds 41,171 shares of OGN stock, worth $614,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,171
Previous 29,509 39.52%
Holding current value
$614,271
Previous $610,000 29.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $217,496 - $268,575
11,662 Added 39.52%
41,171 $787,000
Q2 2024

Aug 07, 2024

BUY
$17.45 - $21.96 $223,045 - $280,692
12,782 Added 76.42%
29,509 $610,000
Q1 2024

May 14, 2024

BUY
$13.78 - $18.8 $468 - $639
34 Added 0.2%
16,727 $314,000
Q4 2023

Feb 13, 2024

BUY
$10.95 - $17.32 $182,788 - $289,122
16,693 New
16,693 $240,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $862 - $1,236
52 Added 0.32%
16,427 $285,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $314,987 - $402,601
-16,346 Reduced 49.96%
16,375 $340,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $232,771 - $348,613
10,867 Added 49.73%
32,721 $769,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $25,850 - $31,728
-1,109 Reduced 4.83%
21,854 $610,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $20.4 Million - $29.8 Million
-870,528 Reduced 97.43%
22,963 $538,000
Q2 2022

Aug 12, 2022

BUY
$31.66 - $38.9 $15.8 Million - $19.4 Million
499,629 Added 126.85%
893,491 $30.2 Million
Q1 2022

May 11, 2022

BUY
$30.45 - $39.36 $11.7 Million - $15.1 Million
383,744 Added 3792.69%
393,862 $13.8 Million
Q4 2021

Feb 07, 2022

BUY
$28.67 - $37.13 $44,696 - $57,885
1,559 Added 18.21%
10,118 $308,000
Q3 2021

Nov 10, 2021

BUY
$28.63 - $35.64 $245,044 - $305,042
8,559 New
8,559 $280,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.